;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Bionomics financial update

    Bionomics Ltd. (ASX:BNO; OTCBB:BMICY), Thebarton, Australia Business: Neurology, Cancer, Genomics Date announced: 2014-11-11 Note: The company secured $10 million in non-dilutive funding from Silicon Valley Bank.

    Published on 11/24/2014
  • Cempra financial update

    Cempra Inc. (NASDAQ:CEMP), Chapel Hill, N.C. Business: Infectious Date announced: 2014-11-19 Note: Cempra filed a shelf registration covering the sale of up to $150 million of its securities. The company, which closed …

    Published on 11/24/2014
  • FibroGen financial update

    FibroGen Inc. (NASDAQ:FGEN), San Francisco, Calif. Business: Hematology, Renal, Pulmonary Date announced: 2014-11-17 Note: FibroGen raised $21.9 million through the sale of 1.2 million shares at $18 to cover the …

    Published on 11/24/2014
  • iBio financial update

    iBio Inc. (NYSE-M:IBIO), Newark, Del. Business: Infectious Date announced: 2014-11-20 Note: iBio filed a shelf registration covering the sale of up to $100 million of its securities. The company, which closed at $1.07 …

    Published on 11/24/2014
  • Lion Biotechnologies financial update

    Lion Biotechnologies Inc. (OTCQB:LBIO), Woodland Hills, Calif. Business: Cancer Date announced: 2014-11-20 Note: Lion Biotechnologies filed a shelf registration covering the sale of up to $100 million of its securities.…

    Published on 11/24/2014
  • Tolero Pharmaceuticals financial update

    Tolero Pharmaceuticals Inc., Lehi, Utah Business: Cancer, Autoimmune Date announced: 2014-11-05 Note: Tolero raised $7.8 million in a second tranche of a series Beta financing, bringing the total raised in the round to…

    Published on 11/24/2014
  • Valeant Pharmaceuticals financial update

    Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Laval, Quebec Business: Neurology, Dermatology Date announced: 2014-11-20 Note: Valeant said its board authorized a repurchase program of up to $2 billion …

    Published on 11/24/2014
  • Zoetis financial update

    Zoetis Inc. (NYSE:ZTS), Madison, N.J. Business: Veterinary Date announced: 2014-11-18 Note: Zoetis said its board authorized a share repurchase program of up to $500 million. Zoetis, which closed Friday at $43.87, has …

    Published on 11/24/2014
  • Bellicum proposes IPO

    Bellicum Pharmaceuticals Inc., Houston, Texas Business: Cancer Date announced: 2014-11-18 Type: IPO To be raised: Up to $115 million Shares: TBD Price: TBD Underwriters: Jefferies; Citigroup; Piper Jaffray Note: The …

    Published on 11/24/2014
  • Celsus Therapeutics proposes follow-on

    Celsus Therapeutics plc (NASDAQ:CLTX), London, U.K. Business: Inflammation, Dermatology Date announced: 2014-11-20 Type: Follow-on To be raised: Up to $46 million Shares: TBD Price prior: $5.32 Underwriters: Cowen; …

    Published on 11/24/2014
  • Juno Therapeutics proposes IPO

    Juno Therapeutics Inc., Seattle, Wash. Business: Cancer Date announced: 2014-11-17 Type: IPO To be raised: Up to $150 million Shares: TBD Price: TBD Underwriters: Morgan Stanley; JPMorgan; Goldman Sachs; Leerink …

    Published on 11/24/2014
  • Onxeo proposes rights offering

    Onxeo S.A. (Euronext:ONXEO; CSE:ONXEO), Paris, France Business: Cancer Date announced: 2014-11-18 Type: Rights offering To be raised: Up to ?35.4 million ($44.1 million) Shares: 7.9 million Price: ?4.50 Shares …

    Published on 11/24/2014
  • Trevena proposes follow-on

    Trevena Inc. (NASDAQ:TRVN), King of Prussia, Pa. Business: Cardiovascular, Neurology, Autoimmune Date announced: 2014-11-20 Type: Follow-on To be raised: Up to $40 million Shares: TBD Price prior: $5.59 Underwriters: …

    Published on 11/24/2014
  • DermTech withdraws IPO

    DermTech International Inc., La Jolla, Calif. Business: Supply/Service, Diagnostic Date announced: 2014-11-13 Type: IPO Underwriters: Maxim Group; Feltl Note: DermTech withdrew its IPO on NASDAQ.

    Published on 11/24/2014
  • Histogenics amends IPO

    Histogenics Corp., Waltham, Mass. Business: Musculoskeletal Date announced: 2014-11-14 Type: IPO To be raised: Up to $64.3 million Shares: 4.3 million Price: $13-$15 Underwriters: Cowen; Needham; Canaccord; BTIG …

    Published on 11/17/2014
  • Kane amends private placement of units

    Kane Biotech Inc. (TSX-V:KNE), Winnipeg, Manitoba Business: Drug delivery, Dermatology Date announced: 2014-11-10 Type: Private placement of units To be raised: Up to C$1.2 million ($1.1 million) Units: 24 million Price…

    Published on 11/17/2014
  • Neothetics amends IPO

    Neothetics Inc., San Diego, Calif. Business: Ophthalmic, Endocrine/Metabolic Date announced: 2014-11-10 Type: IPO To be raised: Up to $64.5 million Shares: 4.3 million Price: $13-$15 Underwriters: Piper Jaffray; …

    Published on 11/17/2014
  • S1 Biopharma amends IPO

    S1 Biopharma Inc., New York, N.Y. Business: Genitourinary Date announced: 2014-11-10 Type: IPO To be raised: Up to $44.3 million Shares: 2.8 million Price: $12-$14 Underwriters: MLV; Northland Securities Inc. …

    Published on 11/17/2014
  • BeiGene completes venture financing

    BeiGene Co. Ltd., Beijing, China Business: Cancer Date completed: 2014-11-14 Type: Venture financing Raised: RMB450 million ($73.5 million) Investors: Strategic investors; angel investors; CITIC Capital Partners; …

    Published on 11/17/2014
  • Blueprint Medicines completes venture financing

    Blueprint Medicines, Cambridge, Mass. Business: Cancer Date completed: 2014-11-12 Type: Venture financing Raised: $50 million Investors: Partner Fund Management; Wellington Management; RA Capital Management; Tavistock …

    Published on 11/17/2014
  • Capnia completes IPO

    Capnia Inc. (NASDAQ:CAPN), Redwood City, Calif. Business: Diagnostic Date completed: 2014-11-13 Type: IPO Raised: $10.7 million Shares: 1.7 million Price: $6.50 (unit) Shares after offering: 6.5 million Underwriters: …

    Published on 11/17/2014
  • Cellectis completes warrant exercise

    Cellectis S.A. (Euronext:ALCLS), Paris, France Business: Gene/Cell therapy, Genomics Date completed: 2014-11-12 Type: Warrant exercise Raised: EUR13.2 million ($16.5 million) Shares: 1.5 million Shares after offering: …

    Published on 11/17/2014
  • Coronado Biosciences completes private placement

    Coronado Biosciences Inc. (NASDAQ:CNDO), Burlington, Mass. Business: Autoimmune, Cancer Date completed: 2014-11-07 Type: Private placement Raised: $3.5 million Shares: 2.2 million Price: $1.61 Shares after offering: 46.…

    Published on 11/17/2014
  • Critical Outcome Technologies completes private placement of units

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer, Autoimmune, Infectious Date completed: 2014-11-07 Type: Private placement of units Raised: $1.2 million Units: 5.1 million …

    Published on 11/17/2014
  • FibroGen completes IPO

    FibroGen Inc. (NASDAQ:FGEN), San Francisco, Calif. Business: Hematology, Renal, Pulmonary Date completed: 2014-11-14 Type: IPO Raised: $145.8 million Shares: 8.1 million Price: $18 Shares after offering: 56.7 million …

    Published on 11/17/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993